TSC2 and angiomyolipoma: Angiomyolipoma samples from patients with either sporadic or TSC-associated tumors often display loss of the wild type allele (loss of heterozygosity, LOH) for TSC2 [17, 18] [19], as well as evidence of activation of mTORC1 [12, 13, 19].